Advancing Maternal Safety: AWHONN Secures $500,000 Merck for Mothers Grant to Standardize Postpartum Emergency Care

WASHINGTON, D.C. — In a pivotal move to address the persistent crisis of maternal mortality in the United States, the Association of Women’s Health, Obstetric and Neonatal Nurses (AWHONN) announced on July 14, 2026, that it has been awarded a $500,000 grant from Merck for Mothers. This significant financial injection is earmarked for the development and nationwide implementation of the POST-BIRTH Triage Index (PBTI), a first-of-its-kind standardized tool designed to transform how emergency departments, urgent care centers, and freestanding emergency facilities identify and treat postpartum complications.

n

As the United States continues to grapple with maternal mortality rates that exceed those of other high-income nations, this initiative represents a critical systemic intervention. By focusing on the "fourth trimester"—the year following childbirth—AWHONN and Merck for Mothers aim to bridge a lethal gap in the healthcare continuum where many women currently fall through the cracks of the medical system.

n


n

I. Main Facts: A New Standard for Postpartum Survival

n

The core of the $500,000 grant lies in the creation of the POST-BIRTH Triage Index (PBTI). While the medical community has long utilized triage systems to prioritize trauma or cardiac events, a specialized, validated index for postpartum patients in non-obstetric settings has been conspicuously absent.

n

The PBTI Objective

n

The PBTI is designed to be a clinical decision-support tool. Its primary function is to provide non-obstetric clinicians—nurses and physicians in general emergency rooms and urgent care clinics—with a structured framework to recognize "red flag" symptoms that may appear unrelated to pregnancy to the untrained eye but are, in fact, life-threatening postpartum complications.

n

Addressing the Post-Discharge Gap

n

Currently, AWHONN’s POST-BIRTH Warning Signs (PBWS) program reaches approximately 1.7 million patients annually. While PBWS focuses on educating the mother to recognize symptoms herself, the PBTI shifts the focus to the healthcare provider. The initiative recognizes that even when a mother identifies a problem and seeks help, the receiving facility may not have the specialized obstetric knowledge to treat her effectively.

n

Scope of the Grant

n

The funding will facilitate a multi-year rollout beginning in 2026. This includes:

n

    n

  • The formation of a multidisciplinary expert panel comprising obstetricians, emergency medicine physicians, nurses, and patient advocates.
  • n

  • The execution of three rigorous research studies to validate the triage index.
  • n

  • The development of clinical protocols and digital resources to integrate the PBTI into existing hospital electronic health records (EHR).
  • n

n


n

II. Chronology: From Education to Clinical Standardization

n

The journey toward the PBTI began years ago with the recognition that the period immediately following hospital discharge is the most dangerous time for new mothers.

n

The Foundation: The PBWS Program

n

AWHONN’s efforts gained significant traction with the Post-Birth Warning Signs (PBWS) program. This initiative was designed to empower mothers with a simple acronym and checklist of symptoms—such as chest pain, seizures, or thoughts of self-harm—that require immediate medical attention. Over the last decade, this program has been integrated into hospital discharge protocols across the country and has become a cornerstone of statewide maternal mortality review committee (MMRC) recommendations.

n

Identifying the Crisis in the ER (2023-2025)

n

Leading up to the 2026 grant, research conducted across 23 emergency departments in 17 states highlighted a harrowing reality: clinicians in non-obstetric settings often lacked the training to recognize postpartum emergencies. Many emergency department (ED) staff were found to be unaware of a patient’s recent pregnancy status unless specifically told, and even then, the protocols for conditions like postpartum preeclampsia or cardiomyopathy were not standardized.

n

The 2026 Milestone

n

On July 14, 2026, the partnership with Merck for Mothers was formalized. This grant marks the transition from "patient education" to "clinical system overhaul." The implementation schedule for late 2026 and 2027 involves moving the PBTI from a conceptual framework into a validated clinical tool through a series of pilot programs in diverse geographic and socioeconomic regions.

n


n

III. Supporting Data: The Stark Reality of Postpartum Mortality

n

The necessity of the PBTI is underscored by data from the Centers for Disease Control and Prevention (CDC) and various peer-reviewed maternal health studies.

n

The Fatal Timeline

n

Data indicates that more than 50% of pregnancy-related deaths occur between seven days and one year after delivery. This is the period when the mother is no longer under the intensive surveillance of the labor and delivery ward.

  • Preventability: Experts estimate that over 80% of these postpartum deaths are preventable with timely and appropriate medical intervention.
  • The "Non-OB" Factor: A significant percentage of women experiencing postpartum emergencies do not return to their birthing hospital. Instead, they visit the nearest emergency room or urgent care center. Research shows that these "non-obstetric" settings are where the highest risk of misdiagnosis occurs.

Clinical Challenges

The PBTI addresses specific conditions that often present with vague symptoms:

  1. Postpartum Preeclampsia: Can occur up to six weeks after birth. A headache in the ER might be treated as a migraine, while it is actually a precursor to a stroke or seizure.
  2. Postpartum Hemorrhage: Delayed hemorrhage can occur days after discharge, requiring rapid blood product intervention.
  3. Peripartum Cardiomyopathy: Shortness of breath may be dismissed as exhaustion or anxiety, masking heart failure.
  4. Infection/Sepsis: Fever and pain can be misattributed to the general recovery process rather than a systemic infection.

The grant-funded research will specifically target these gaps, ensuring the PBTI provides high sensitivity for these conditions.


IV. Official Responses: A Unified Vision for Change

Leaders from both the nursing and corporate sectors have emphasized that this grant is not just about funding—it is about a fundamental shift in healthcare philosophy.

AWHONN Leadership

Jonathan Webb, MBA, MPH, the CEO of AWHONN, framed the grant as a life-saving investment.

"This investment represents a significant step forward in improving maternal safety during one of the most vulnerable periods in a woman’s healthcare journey," Webb stated. "By developing the first validated postpartum-specific triage index for emergency and urgent care settings, we can help clinicians identify life-threatening complications more quickly, improve care coordination and ultimately save lives."

Webb further noted that nurses are often the first line of defense in triage, and providing them with a validated tool empowers them to advocate for their patients more effectively within the hospital hierarchy.

Merck for Mothers Perspective

Jacquelyn Caglia, Head of Merck for Mothers, highlighted the organization’s commitment to global maternal health equity.

"Merck for Mothers believes that every mother deserves access to high-quality, timely care throughout the postpartum period," Caglia said. "We are honored to support AWHONN’s efforts to expand this important work, building on the success of the Post-Birth Warning Signs program and helping to strengthen systems providing care for families across the United States during this critical time."

The partnership underscores a "systems-level" approach to philanthropy, where corporate resources are used to build infrastructure that remains in place long after the grant period ends.


V. Implications: The Future of Maternal Healthcare

The introduction of the PBTI has far-reaching implications for the American healthcare landscape, touching on medical education, health equity, and hospital policy.

1. Standardization of Care

Currently, the quality of postpartum emergency care is a "geographic lottery." A woman’s survival can depend on whether the ER she visits has a strong relationship with an OB-GYN department. The PBTI seeks to eliminate this variance by creating a universal standard. Regardless of whether a mother is in a rural urgent care or a major metropolitan ER, the triage process will be the same.

2. Impact on Health Equity

Maternal mortality in the U.S. disproportionately affects Black and Indigenous women, who are three to four times more likely to die from pregnancy-related causes than white women. By standardizing triage through the PBTI, the medical community can reduce the impact of implicit bias. A standardized tool relies on objective clinical data rather than subjective provider assessment, which is a proven strategy for reducing disparities in care.

3. Strengthening the Healthcare Workforce

The grant also funds the expansion of maternal and newborn education resources. As the healthcare system faces staffing shortages, particularly in specialized nursing, providing generalist nurses with easy-to-use, evidence-based tools like the PBTI reduces the cognitive load and increases clinical confidence.

4. Integration with Technology

The move toward digital health means the PBTI is likely to be integrated into Electronic Health Record (EHR) systems. This would allow for "best practice alerts" to trigger automatically when a patient’s chart indicates a recent birth and certain symptoms are entered, creating a digital safety net for new mothers.

5. Policy and Advocacy

The success of this program will likely influence future legislation. As AWHONN collects data from the three research studies funded by this grant, they will have the evidence needed to advocate for federal and state policies that mandate postpartum triage training for all emergency personnel.


Conclusion: A Critical Step Toward Zero Preventable Deaths

The $500,000 grant from Merck for Mothers to AWHONN is more than a financial transaction; it is a catalyst for a necessary cultural and clinical shift. By acknowledging that the postpartum period does not end at the hospital exit, and by equipping the entire medical ecosystem—not just obstetricians—with the tools to intervene, the PBTI project stands to save thousands of lives.

As implementation begins in 2026, the eyes of the healthcare community will be on AWHONN. The transition from the "Post-Birth Warning Signs" education for mothers to the "Post-Birth Triage Index" for providers completes the circle of care, ensuring that when a mother asks for help, the system is finally ready to answer.


About AWHONN
The Association of Women’s Health, Obstetric and Neonatal Nurses (AWHONN) is a 501(c)3 nonprofit membership organization. Their mission is to empower and support nurses caring for women, newborns, and their families through research, education, and advocacy.

About Merck for Mothers
Merck for Mothers is Merck’s global initiative to help create a world where no woman has to die while giving life. The program focuses on improving the quality of maternal care and expanding access to family planning.

Media Contact:
Shannon Doolin
202-261-2410
[email protected]

Leave a Reply

Your email address will not be published. Required fields are marked *

Lyrica Pills
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.